OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
-0.22
-8.24%
The company has not provided financial reports or other disclosures to OTC Markets Group.
Form Type Form Type | Received Received | Period End Date Period End Date | Report Report |
---|---|---|---|
8-K | 08/05/2025 | 08/05/2025 | |
10-Q | 08/04/2025 | 06/30/2025 | |
D | 08/04/2025 | ||
3 | 08/01/2025 | 07/31/2025 | |
4 | 08/01/2025 | 07/30/2025 | |
4 | 08/01/2025 | 07/30/2025 | |
4 | 08/01/2025 | 07/30/2025 | |
4 | 08/01/2025 | 07/30/2025 | |
8-K | 07/31/2025 | 07/30/2025 | |
4 | 07/23/2025 | 06/29/2025 |
No insider disclosure available for NSPR.
Trans Date Trans Date | Filer Filer | Ownership Ownership | Type Type | Price Price | Shares Traded Shares Traded | Shares Held Shares Held |
---|---|---|---|---|---|---|
07/31/2025 | COHEN RAYMOND W Director | Direct | 48,387 | |||
07/30/2025 | SLOSMAN MARVIN Officer | Direct | Buy | 2.42 | 10,330 | 2,420,866 |
07/30/2025 | KESTER THOMAS J Director | Direct | Buy | 2.42 | 30,991 | 420,758 |
07/30/2025 | STUKA PAUL Director | Indirect | Buy | 2.42 | 20,661 | 444,195 |
07/30/2025 | ROUBIN GARY S Director | Direct | Buy | 2.42 | 41,322 | 608,425 |
06/29/2025 | BERMAN MICHAEL Director | Indirect | Option Execute | 1.3827 | 61,248 | 244,994 |
07/11/2025 | KESTER THOMAS J Director | Direct | Option Execute | 1.3827 | 30,624 | 389,767 |
07/01/2025 | STUKA PAUL Director | Indirect | Option Execute | 1.3827 | 87,500 | 423,534 |
06/25/2025 | ROUBIN GARY S Director | Direct | Option Execute | 1.3827 | 30,624 | 567,103 |
06/25/2025 | LAWLESS MICHAEL A Officer | Direct | 465,000 |